购物车
- 全部删除
- 您的购物车当前为空
Pirepemat (IRL752) is a cortical-preferring catecholamine agent that enhances cognition. It is utilized in the investigation of Parkinson's disease.
Pirepemat (IRL752) is a cortical-preferring catecholamine agent that enhances cognition. It is utilized in the investigation of Parkinson's disease.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
25 mg | ¥ 7,870 | 期货 | |
50 mg | ¥ 11,900 | 期货 |
产品描述 | Pirepemat (IRL752) is a cortical-preferring catecholamine agent that enhances cognition. It is utilized in the investigation of Parkinson's disease. |
体外活性 | IRL752 displayed its highest in vitro affinities for 5-HT and NA-related targets[2]. |
体内活性 | IRL752 (3.7-100 μmol/kg, s.c.) has no significant effect on acute hyper-dopaminergic or hypo-glutamatergic motor responses, but reversed deficits resulting from hypomonoaminergic function[2]. Animal Model: Normal rats[2]. Dosage: 3.7-100 μmol/kg. Administration: s.c., 30 min prior to testing. Result: Induced dose-dependent and regio-selective alterations in brain monoamine transmission indices and gene expression. |
别名 | IRL752 |
分子量 | 213.228 |
分子式 | C11H13F2NO |
CAS No. | 1227638-29-0 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容